These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24077900)

  • 1. Experiences of gout-related disability from the patients' perspective: a mixed methods study.
    ten Klooster PM; Vonkeman HE; Voshaar MA; Bode C; van de Laar MA
    Clin Rheumatol; 2014 Aug; 33(8):1145-54. PubMed ID: 24077900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout.
    Taylor WJ; Colvine K; Gregory K; Collis J; McQueen FM; Dalbeth N
    Clin Exp Rheumatol; 2008; 26(4):620-6. PubMed ID: 18799093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of measures of functional disability in patients with gout.
    Ten Klooster PM; Oude Voshaar MA; Taal E; van de Laar MA
    Rheumatology (Oxford); 2011 Apr; 50(4):709-13. PubMed ID: 21131272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in gout in primary care: Baseline findings from a cohort study.
    Chandratre P; Mallen C; Richardson J; Muller S; Hider S; Rome K; Blagojevic-Bucknall M; Roddy E
    Semin Arthritis Rheum; 2018 Aug; 48(1):61-69. PubMed ID: 29398125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Health Assessment Questionnaire disability index in patients with gout.
    Alvarez-Hernández E; Peláez-Ballestas I; Vázquez-Mellado J; Terán-Estrada L; Bernard-Medina AG; Espinoza J; Aceves-Avila FJ; Goycochea-Robles MV; Garza M; Ventura L; Burgos-Vargas R;
    Arthritis Rheum; 2008 May; 59(5):665-9. PubMed ID: 18438898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disability due to gouty arthritis.
    ten Klooster PM; Vonkeman HE; van de Laar MA
    Curr Opin Rheumatol; 2012 Mar; 24(2):139-44. PubMed ID: 22227879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with change in health-related quality of life in people with gout: a 3-year prospective cohort study in primary care.
    Watson L; Belcher J; Nicholls E; Chandratre P; Blagojevic-Bucknall M; Hider S; Lawton SA; Mallen CD; Muller S; Rome K; Roddy E
    Rheumatology (Oxford); 2023 Aug; 62(8):2748-2756. PubMed ID: 36545704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe tophaceous gout and disability: changes in the past 15 years.
    López López CO; Lugo EF; Alvarez-Hernández E; Peláez-Ballestas I; Burgos-Vargas R; Vázquez-Mellado J
    Clin Rheumatol; 2017 Jan; 36(1):199-204. PubMed ID: 27631961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions.
    Tatlock S; Rüdell K; Panter C; Arbuckle R; Harrold LR; Taylor WJ; Symonds T
    Patient; 2017 Feb; 10(1):65-79. PubMed ID: 27384670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR).
    Scire CA; Manara M; Cimmino MA; Govoni M; Salaffi F; Punzi L; Monti MC; Carrara G; Montecucco C; Matucci-Cerinic M; Minisola G;
    Arthritis Res Ther; 2013 Aug; 15(5):R101. PubMed ID: 24004577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gout Assessment Questionnaire 2.0: cross-cultural translation into Dutch, aspects of validity and linking to the International Classification of Functioning, Disability and Health.
    Spaetgens B; van der Linden S; Boonen A
    Rheumatology (Oxford); 2014 Apr; 53(4):678-85. PubMed ID: 24357808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and disability in patients with treatment-failure gout.
    Becker MA; Schumacher HR; Benjamin KL; Gorevic P; Greenwald M; Fessel J; Edwards L; Kawata AK; Frank L; Waltrip R; Maroli A; Huang B; ; Sundy JS
    J Rheumatol; 2009 May; 36(5):1041-8. PubMed ID: 19332629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in health-related quality of life and functional ability in patients with gout.
    Singh JA; Bharat A; Khanna D; Aquino-Beaton C; Persselin JE; Duffy E; Elashoff D; Khanna PP
    Rheumatology (Oxford); 2017 Jan; 56(1):103-112. PubMed ID: 28028159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Gout Impact Scale in a longitudinal observational study of patients with gout.
    Wallace B; Khanna D; Aquino-Beaton C; Singh JA; Duffy E; Elashoff D; Khanna PP
    Rheumatology (Oxford); 2016 Jun; 55(6):982-90. PubMed ID: 26888852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity.
    Wood R; Fermer S; Ramachandran S; Baumgartner S; Morlock R
    J Rheumatol; 2016 Oct; 43(10):1897-1903. PubMed ID: 27036386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and prospective evaluation of CAPLET, a cancer ambulatory patient physical function longitudinal evaluation tool for routine clinical practice.
    Hall E; Tam E; Liang M; Zhang Q; Liu L; Wong L; Sarabia S; Yeung S; Gill G; Eng L; Perez-Cosio A; Brown MC; Xu W; Li M; Mittmann N; Jones J; Howell D; Liu G
    Support Care Cancer; 2019 Feb; 27(2):521-530. PubMed ID: 29982902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement properties of the Health Assessment Questionnaire Disability Index for generalized osteoarthritis.
    Cuperus N; Mahler EA; Vliet Vlieland TP; Hoogeboom TJ; van den Ende CH
    Rheumatology (Oxford); 2015 May; 54(5):821-6. PubMed ID: 25313146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of activity limitation in people with gout: a prospective study.
    Stewart S; Rome K; Eason A; House ME; Horne A; Doyle AJ; Knight J; Taylor WJ; Dalbeth N
    Clin Rheumatol; 2018 Aug; 37(8):2213-2219. PubMed ID: 29680870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.
    Strand V; Khanna D; Singh JA; Forsythe A; Edwards NL
    J Rheumatol; 2012 Jul; 39(7):1450-7. PubMed ID: 22660805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in gout: a systematic review.
    Chandratre P; Roddy E; Clarson L; Richardson J; Hider SL; Mallen CD
    Rheumatology (Oxford); 2013 Nov; 52(11):2031-40. PubMed ID: 23934311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.